Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.8 |